Biologic Tapering in axSpA: What Research Says and What it Means for Patients

Rheumatologist Dr. Marina Magrey discusses her latest research on biologic DMARD dose tapering in axial spondyloarthritis, outlining when it may be appropriate, its risks and benefits, and key considerations for patients.

Episode metadata supplied by the publisher feed · Published Oct 29, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Biologic Tapering in axSpA: What Research Says and What it Means for Patients

0:00 31:49

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Spondycast?

This episode is 31 minutes long.

When was this Spondycast episode published?

This episode was published on October 29, 2025.

Can I download this Spondycast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!